Abstract
In a double blind randomised trial, we found no evidence that nebulised ipratropium bromide was of clinical benefit in acute bronchiolitis.
Publication types
-
Clinical Trial
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acute Disease
-
Atropine Derivatives / therapeutic use*
-
Bronchiolitis, Viral / drug therapy*
-
Clinical Trials as Topic
-
Double-Blind Method
-
Female
-
Humans
-
Infant
-
Ipratropium / therapeutic use*
-
Male
-
Random Allocation
-
Respiratory Syncytial Viruses
-
Respirovirus Infections / drug therapy
Substances
-
Atropine Derivatives
-
Ipratropium